Description: The US and EU are each pursuing modernization of their regulatory frameworks. The purpose of this paper is to provide a discussion of the emerging developments, the historical contexts or drivers of each, and potential implications for insurers. The paper discusses some of the global, wider financial services, and insurance specific activities underway that are influencing solvency developments for life insurers. It provides an overview of the differences in the current US and EU regimes and the regulatory changes underway. The paper then identifies key valuation implications, the impact on pricing and product design, and risk management implications.

Description: A multiway typology of measures of aging, longevity and superlongevity is presented, with measures classified as measures of aging and longevity, direct and indirect measures of aging and longevity, and measures based on population data, death statistics and life table functions.

Description: A call for project proposals to study the impacts of climate-induced migration on various areas which can influence the delivery of services and availability of insurance coverages.

Description: An article recapping the SOA's participation in the NAIC Summer 2023 meeting.

Description: A summary of the SOA Research Institute's participation in the NAIC Spring 2025 National meeting

Description: This session will cover the regulatory testing requirements issued by Colorado in its SB21-169 regulation, New York Insurance Circular Letter No. 7 issued in 2024, as well as other US States. It will also explore the actual implementation of these requirements on a company using Large Language Model on external data for life underwriting.

Description: Large Language Models can help you write emails, code in SQL, R and Python, and be more efficient. But should you use it? Let's review the professional guidance available to actuaries, including the work from the Academy of Actuaries.

Description: Traditional Medicare [TM] has many coverage gaps and no out-of-pocket maximum. Most members must purchase a Medicare Supplement Plan and a Part D plan for pharmacy coverage. Over 50% of members have opted for a Medicare Advantage [MA] plan that replaces TM and the need to purchase a Supplement and (in most cases) a Part D plan. All this for less cost to the member, but at a greater overall cost to the federal government even though MA plans provide TM benefits for less than it costs the government. The attendee will learn why this occurs. However, given these facts, the focus of the session will be on the future of Medicare: namely, should the parameters regarding MA bids and payments be limited to what is paid for TM, or can we take the best administrative techniques of MA and TM to provide more robust benefits for all Medicare members at a cost no greater than the government is currently paying? Or is there an even better idea?

Description: Prescription drug markets are undergoing rapid change - significant policy changes implemented through the Inflation Reduction Act, Congressional interest in long-awaited 340b reform, and a growing direct-to-consumer market have already changed the landscape significantly. The ongoing effects of these changes will continue to evolve for many years. Hear from leading prescription drug actuaries and pharmacy policy experts on what these changes mean for prescription drug markets and US healthcare more broadly.

Description: How are regulation and innovation intertwined? How do we regulate AI/ML in the insurance industry? We will cover how regulators are striking the balance between protection of their constituents and supporting innovation. We will zoom into the case of Predictive Analytics and the regulatory attempt at avoiding undue discrimination. Let's discuss what this really means.